Z. Jiang - Concepedia

Author

Z. Jiang

Also Known As

Z. Jiang, Ze Fei Jiang, Ze fei Jiang, Ze-Kai JIANG, Ze-fei Jiang

Publications

172

Citations

H-Index

Concepts

All Affiliations

Z. Jiang is an author at Chinese PLA General Hospital specializing in breast cancer, cancer therapeutics, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	57
2	Cancer Therapeutics	3	3	57
3	Pharmacology	2	2	31
4	Cancer Cell Biology	2	2	42
5	Immunology	1	1	16

Z. Jiang

Publications

159

Citations

H-Index

Page 1

	Year	Citations
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study Qing Yuan Zhang, Tao Sun, Yong Yin, Therapeutic Advances in Medical Oncology	2020	102
328TiP Phase III study of trastuzumab deruxtecan (T-DXd) with or without pertuzumab vs a taxane, trastuzumab and pertuzumab in first-line (1L), human epidermal growth factor receptor 2–positive (HER2+) metastatic breast cancer (mBC): DESTINY-Breast09 Sara M. Tolaney, Romualdo Barroso‐Sousa, Z. Jiang, Annals of Oncology Metastatic Breast CancerBreast OncologyMedicineTumor ImmunityCancer Cell Biology	2021	26
Safety and Efficacy of Neratinib (HKI-272) in Combination with Paclitaxel in ErbB2+ Metastatic Breast Cancer. Louis W.C. Chow, Sudeep Gupta, Dawn L. Hershman, Cancer Research Tumor BiologyPart 1OncologyBreast OncologyPart 2	2009	16
MONARCHplus: A phase III trial of abemaciclib plus nonsteroidal aromatase inhibitor (NSAI) or fulvestrant (F) for women with HR+/HER2- advanced breast cancer (ABC) Z. Jiang, Xiaolin Hu, Q. Zhang, Annals of Oncology Breast OncologyOncologyMedicinePhase Iii TrialAromatase	2019	15

Page 1